This is a summary of the European public assessment report (EPAR) for Savene. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Savene.
Therapeutic Indication
Savene is indicated for the treatment of anthracycline extravasation.
Therapeutic Area (MeSH)
ATC Code
V03AF02
ATC Item
N/A
Pharmacotherapeutic Group
All other therapeutic products
Active Substance (Summary)
INN / Common Names
EMA Name
Savene
Medicine Name
Savene
Aliases
N/ANo risk management plan link.
